menthol has been researched along with Headache in 4 studies
Menthol: A monoterpene cyclohexanol produced from mint oils.
Headache: The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.
Excerpt | Relevance | Reference |
---|---|---|
"The objective of this study was to determine associations between cigarette smoking and the existence of headache in a nationally representative sample, with attention to differences in effect estimates between mentholated and non-mentholated cigarettes smoking." | 7.83 | Association Between Overall and Mentholated Cigarette Smoking With Headache in a Nationally Representative Sample. ( Estus, S; Gan, WQ; Smith, JH, 2016) |
"The objective of this study was to determine associations between cigarette smoking and the existence of headache in a nationally representative sample, with attention to differences in effect estimates between mentholated and non-mentholated cigarettes smoking." | 3.83 | Association Between Overall and Mentholated Cigarette Smoking With Headache in a Nationally Representative Sample. ( Estus, S; Gan, WQ; Smith, JH, 2016) |
"The mean migraine duration was 18." | 3.11 | A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study. ( Arkuszewski, M; Ecochard, L; Kim, BK; Li, Z; Lian, Y; Su, W; Wan, Q; Wang, H; Wang, SJ; Wen, S; Yin, F; Yu, S; Yu, T; Zhou, J, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Yu, S | 3 |
Kim, BK | 3 |
Wang, H | 3 |
Zhou, J | 3 |
Wan, Q | 3 |
Yu, T | 3 |
Lian, Y | 3 |
Arkuszewski, M | 3 |
Ecochard, L | 3 |
Wen, S | 3 |
Yin, F | 3 |
Li, Z | 3 |
Su, W | 3 |
Wang, SJ | 3 |
D'Ruiz, CD | 1 |
Graff, DW | 1 |
Yan, XS | 1 |
Gan, WQ | 1 |
Estus, S | 1 |
Smith, JH | 1 |
PAPA, CM | 1 |
SHELLEY, WB | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Characterization of Nicotine Exposure and Urge-to-Smoke Following a Single Controlled Administration and Short-Term Ad Lib Use of Electronic Cigarettes and Conventional Cigarettes in Adult Smokers[NCT02210754] | 24 participants (Actual) | Interventional | 2014-03-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 trials available for menthol and Headache
Article | Year |
---|---|
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho | 2022 |
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho | 2022 |
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho | 2022 |
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho | 2022 |
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho | 2022 |
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho | 2022 |
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho | 2022 |
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho | 2022 |
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho | 2022 |
Nicotine delivery, tolerability and reduction of smoking urge in smokers following short-term use of one brand of electronic cigarettes.
Topics: Adult; Cough; Craving; Cross-Over Studies; Dizziness; Electronic Nicotine Delivery Systems; Female; | 2015 |
2 other studies available for menthol and Headache
Article | Year |
---|---|
Association Between Overall and Mentholated Cigarette Smoking With Headache in a Nationally Representative Sample.
Topics: Adult; Cross-Sectional Studies; Female; Headache; Humans; Male; Menthol; Middle Aged; Nutrition Surv | 2016 |
MENTHOL HYPERSENSITIVITY; DIAGNOSTIC BASOPHIL RESPONSE IN A PATIENT WITH CHRONIC URTICARIA, FLUSHING, AND HEADACHES.
Topics: Basophils; Dentifrices; Drug Hypersensitivity; Headache; Humans; Hypersensitivity; Leukocyte Count; | 1964 |